Pharma News

EXERCISE MAY BENEFIT PEOPLE WITH PARKINSON'S DISEASE

  • Posted on: 20 January 2015
  • By: PharmaTutor News

Exercise may help people with Parkinson's disease improve their balance, ability to move around and quality of life, according to a new study. In the study, 231 people with Parkinson's disease either received their usual care or took part in an exercise programme of 40 to 60 minutes of balance and leg strengthening exercises three times a week for six months.

GLYCOTHERAPY EMERGING AS NEW TREATMENT FOR BREAST CANCER

  • Posted on: 18 January 2015
  • By: PharmaTutor News

Glycotherapy is useful for those with drug resistant tumour. Less toxification is the beauty of this therapy. Tunicamycin is an antibiotic being used in the therapy. It blocks cell cycle progression and targets only proliferating cells," Professor Dipak K Banerjee at the Department of Biochemistry, School of Medicine, University of Puerto Rico in USA said.

USFDA approves first-of-kind device to treat obesity - VBLOC

The U.S. Food and Drug Administration today approved the Maestro Rechargeable System for certain obese adults, the first weight loss treatment device that targets the nerve pathway between the brain and the stomach that controls feelings of hunger and fullness.
The Maestro Rechargeable System, the first FDA-approved obesity device since 2007, is approved to treat patients aged 18 and older who have not been able to lose weight with a weight loss program, and who have a body mass index of 35 to 45 with at least one other obesity-related condition, such as type 2 diabetes.

IT can be a crucial enabler in addressing health issues : JP Nadda

  • Posted on: 16 January 2015
  • By: PharmaTutor News

Focused academic research can go a long way in strengthening the health sector, and provide solutions to many challenges facing the country in providing accessible and affordable health care to all, particularly the needy and vulnerable. Similarly, IT can play a crucial role as an enabler to address several critical issues in the country’s health sector.

Piramal Enterprises considers potential acquisition of Kentucky based Specialty Pharmaceutical CDMO, Coldstream Laborator ies Inc

  • Posted on: 16 January 2015
  • By: PharmaTutor News

Piramal Enterprises Limited today announced that it is in final stages of discussion with the University of Kentucky for the potential acquisition of Coldstream Laboratories Inc. (‘Coldstream’) for a total consideration of USD 30.65 million.

Bristol-Myers Squibb and California Institute for Biomedical Research (Calibr) sign worldwide research collaboration and license agreement focused on new treatment approaches for Fibrotic Diseases

  • Posted on: 6 January 2015
  • By: PharmaTutor News

Bristol-Myers Squibb (BMS) Company and the California Institute for Biomedical Research (Calibr) entered into a worldwide research collaboration to develop novel small molecule anti-fibrotic therapies, and an exclusive license agreement that allows BMS to develop, manufacture and commercialize Calibr’s preclinical compounds resulting from the collaboration.

Quintiles Named Best Contract Research Organization at SCRIP Awards for Third Consecutive Year

  • Posted on: 6 January 2015
  • By: PharmaTutor News

Quintiles today announced that the company was awarded “Best Contract Research Organization” at the annual SCRIP Awards for the third year in-a-row. This is the company’s fourth award received in this category in the last five years. The SCRIP Awards acknowledge excellence in the biopharmaceutical industry, based on judging by an independent panel of 12 life sciences experts.

Pages